Ovarian Epithelial Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Epithelial Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-12-23Clinical Trial Update: Paclitaxel Plus Carboplatin With or Without Topotecan in Treating Patients With Stage IIB, Stage III, or Stage IV Ovarian Epithelial Cancer [Phase 3]
Phase 3 trial evaluating paclitaxel plus carboplatin with or without topotecan in stage IIB to IV ovarian epithelial cancer. The study also …
-
CLINICAL_TRIALS trial_result · 2015-12-01Clinical Trial Update: Erlotinib Plus Carboplatin and Paclitaxel in Ovarian Carcinoma [Phase 2]
Phase 2 trial evaluating erlotinib in combination with carboplatin and paclitaxel in ovarian and related cancers. The study has completed an…
-
CLINICAL_TRIALS trial_result · 2015-11-27Clinical Trial Update: Oxaliplatin and Topotecan in Advance Ovarian Cancer [Phase 2]
A Phase 2 trial of oxaliplatin and topotecan in advanced or recurrent ovarian cancer was terminated, with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-11-09Clinical Trial Update: AZD2171 in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer [Phase 2]
This update reports results from a Phase 2 study of cediranib (AZD2171) in patients with recurrent ovarian, fallopian tube, or primary perit…
-
CLINICAL_TRIALS trial_result · 2015-08-04Clinical Trial Update: Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer [Phase 1]
Phase 1 trial evaluating the combination of carboplatin, gemcitabine hydrochloride, and stereotactic body radiation therapy in gynecologic c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-07-13Clinical Trial Update: Ixabepilone in Treating Patients With Ovarian Epithelial or Primary Peritoneal Cancer That Has Not Responded to Previous Chemotherapy [Phase 2]
A Phase 2 trial evaluating ixabepilone for ovarian epithelial cancer and primary peritoneal cancer that progressed after prior chemotherapy …
-
CLINICAL_TRIALS trial_result · 2015-06-11Clinical Trial Update: Lapatinib in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Peritoneal Cancer [Phase 2]
A Phase 2 clinical trial updating on lapatinib for persistent or recurrent ovarian epithelial or peritoneal cancer has completed with result…
-
CLINICAL_TRIALS trial_result · 2015-05-25Clinical Trial Update: SJG-136 in Treating Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer That Did Not Respond to Previous Treatment With Cisplatin or Carboplatin [Phase 2]
Phase 2 trial of SJG-136 in recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer that failed cisplatin/carboplatin was…
-
CLINICAL_TRIALS trial_result · 2015-05-12Clinical Trial Update: Bevacizumab in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial evaluating bevacizumab in patients with persistent or recurrent ovarian epithelial cancer or primary peritoneal cance…
-
CLINICAL_TRIALS trial_result · 2015-03-11Clinical Trial Update: VEGF Trap and Docetaxel in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating VEGF Trap with docetaxel in persistent or recurrent ovarian epithelial cancer, primary peritoneal cancer, or fall…
-
CLINICAL_TRIALS trial_result · 2015-01-15Clinical Trial Update: Sunitinib Malate in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
A Phase 2 clinical trial evaluating sunitinib malate in patients with recurrent ovarian epithelial cancer, fallopian tube cancer, or primary…
-
CLINICAL_TRIALS trial_result · 2015-01-15Clinical Trial Update: A Crossover Bioequivalence Study of Intravenously Administered ATI0918 and DOXIL/CAELYX in Patients With Ovarian Cancer [Phase 1]
A Phase 1 crossover bioequivalence study comparing ATI-0918 and liposomal doxorubicin (DOXIL/CAELYX) in patients with ovarian cancer, sponso…
-
CLINICAL_TRIALS trial_result · 2014-11-21Clinical Trial Update: Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma [Phase 2]
Phase 2 trial evaluating Ziv-aflibercept in locally advanced, unresectable, or metastatic gynecologic soft tissue sarcoma has completed with…
-
CLINICAL_TRIALS trial_result · 2014-07-17Clinical Trial Update: A6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial update for A6 in treating persistent or recurrent ovarian epithelial cancer, fallopian tube cancer, or primary perito…
-
CLINICAL_TRIALS trial_result · 2014-06-19Clinical Trial Update: Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Tumors [Phase 1]
Phase 1 study evaluating a combination of temsirolimus, carboplatin, and paclitaxel in adults with advanced solid tumors, including ovarian …
-
CLINICAL_TRIALS trial_result · 2014-04-02Clinical Trial Update: Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors [Phase 1]
Phase 1 update on a veliparib, oxaliplatin, and capecitabine combination in patients with advanced solid tumors. The study, including pancre…
-
CLINICAL_TRIALS trial_result · 2014-01-21Clinical Trial Update: Belinostat and Carboplatin in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Carboplatin or Cisplatin [Phase 2]
Phase 2 trial evaluating belinostat plus carboplatin in recurrent or persistent carboplatin/ cisplatin–refractory ovarian epithelial, fallop…
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Irofulven in Treating Patients With Recurrent or Persistent Ovarian Epithelial or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial evaluating irofulven in recurrent or persistent ovarian epithelial cancer and primary peritoneal cancer; study comple…
-
CLINICAL_TRIALS trial_result · 2013-12-13Clinical Trial Update: Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial update for Paclitaxel albumin-stabilized nanoparticle formulation in recurrent or persistent ovarian epithelial cancer, fallop…
-
CLINICAL_TRIALS trial_result · 2013-11-28Clinical Trial Update: Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignancies [Phase 2]
This report covers results from a Phase 2 trial using the CyberKnife stereotactic radiosurgery system to treat advanced or recurrent gynecol…
-
CLINICAL_TRIALS trial_result · 2013-11-20Clinical Trial Update: Bortezomib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating bortezomib in patients with persistent or recurrent ovarian epithelial cancer or primary peritoneal cancer has comp…
-
CLINICAL_TRIALS trial_result · 2013-11-20Clinical Trial Update: Temsirolimus in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial update of temsirolimus in refractory or recurrent ovarian epithelial, fallopian tube, or primary peritoneal cancer; results po…
-
CLINICAL_TRIALS trial_result · 2013-09-16Clinical Trial Update: Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 3]
Phase 3 trial comparing tamoxifen to thalidomide in women with ovarian epithelial cancer, fallopian tube cancer, or primary peritoneal cance…
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Recurrent Advanced Ovarian Epithelial or Peritoneal Cavity Cancer [Phase 2]
Phase 2 trial evaluating gemcitabine hydrochloride in combination with tanespimycin for recurrent advanced ovarian epithelial cancer or prim…
-
CLINICAL_TRIALS trial_result · 2013-04-10Clinical Trial Update: Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors [Phase 1]
Phase 1 study of Alvespimycin hydrochloride in patients with metastatic or unresectable solid tumors has been completed, evaluating safety a…